South Dakota’s cattle industry is sharply divided as lawmakers advance competing bills — one to ban lab-grown meat by ...

A slew of data releases this past week suggested that at the start of 2026, the job market remained stuck at best — and ...

It is every pet owner’s worst nightmare: their beloved furry friend going missing. In 2025, a dog named Ziggy made a break ...

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

At-home health tests are booming—but are they reliable? Doctors explain which home tests are worth trying, which to skip, and ...

After 23 years in solitary confinement, Alvaro “Xinachtli” Hernandez’s health is failing him. So is the system.

If you have accounts on any of these services, now's a good time to check your security settings. Plus more from a busy week in cybersecurity chaos.

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

A detective investigating a killing stumbled onto a “case within a case,” as he called it, involving long-lost siblings who ...

Local elections administrators across California say they have been preparing for once unthinkable threats to the midterms, from their own federal government.

Faced with potentially losing billions, colleges rallied behind a compromise plan. It now has a thumbs-up from Congress.